Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 16 Liver Neoplasms 7 Pancreatic Neoplasms 4 Cholangiocarcinoma 4 Colorectal Neoplasms 3 Thyroid Nodule 2 Thyroid Diseases 2 Neoplasm Metastasis 2 Gallbladder Neoplasms 2 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Stomach Neoplasms 1 Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1 Recurrence 1 Papillary Thyroid Microcarcinoma 1 Neoplasms, Glandular and Epithelial 1 Neoplasms 1 NSCLC 1 Lung Neoplasms 1 Hypertension, Portal 1 Hyperaldosteronism 1 Hepatitis B 1 Hepatic Metastasis of Colorectal Cancer 1 Head and Neck Neoplasms 1 HCC 1 Colorectal Cancer Liver Metastases 1 Colonic Neoplasms 1 Cholestasis 1 Carcinoma, Non-Small-Cell Lung 1 Cancer Pain 1

Interventions

Gefitinib 5 icotinib 4 Pemetrexed 4 Docetaxel 4 camrelizumab 3 apatinib 3 anlotinib 3 aflutinib 3 Erlotinib Hydrochloride 3 osimertinib 2 dacomitinib 2 Thalidomide 2 Radiosurgery 2 Drug Therapy 2 Carboplatin 2 Afatinib 2 trilaciclib 1 spartalizumab 1 pembrolizumab 1 nimotuzumab 1 famitinib 1 envafolimab 1 Vinorelbine 1 Tyrosine Kinase Inhibitors 1 S 1 (combination) 1 Radiofrequency Ablation 1 Microphysiological Systems 1 Immune Checkpoint Inhibitors 1 Cisplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × NSCLC × Radiofrequency Ablation × Clear all

NCT01105182 2010-04-16

FACPT

The First Affiliated Hospital of Guangzhou Medical University

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡